$AUID
authID Inc.

2013 Q3 Form 10-Q Financial Statement

#000114420413046065 Filed on August 14, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q2 2012 Q4
Revenue $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $240.0K $350.0K
YoY Change
% of Gross Profit
Research & Development $43.00K $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $11.19K $0.00
YoY Change
% of Gross Profit
Operating Expenses $294.7K $8.801K
YoY Change 1073.47%
Operating Profit -$294.7K -$8.801K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$294.7K -$230.0K
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$294.7K -$8.801K
YoY Change 1073.47%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.73 -$0.52
COMMON SHARES
Basic Shares Outstanding 1.500M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2013 Q2 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.849K $8.908K $17.72K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $264.5K $150.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $243.0K $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $243.0K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $264.5K $150.00
Total Long-Term Assets $243.0K $0.00
Total Assets $507.5K $150.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.569K $350.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $1.569K $350.00
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$12.06K -$3.193K
YoY Change
Common Stock $2.993K $2.993K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $505.9K -$200.00
YoY Change
Total Liabilities & Shareholders Equity $507.5K $150.00
YoY Change

Cashflow Statement

Concept 2013 Q3 2013 Q2 2012 Q4
OPERATING ACTIVITIES
Net Income -$294.7K -$8.801K
YoY Change 1073.47%
Depreciation, Depletion And Amortization $11.19K $0.00
YoY Change
Cash From Operating Activities -$50.00K -$240.0K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$20.00K $230.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $20.00K -$230.0K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.950K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 500.0K
YoY Change
NET CHANGE
Cash From Operating Activities -50.00K -240.0K
Cash From Investing Activities 20.00K -230.0K
Cash From Financing Activities 0.000 500.0K
Net Change In Cash -30.00K 30.00K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$50.00K -$240.0K
Capital Expenditures -$20.00K $230.0K
Free Cash Flow -$30.00K -$470.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1950 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
515000 USD
dei Document Type
DocumentType
10-Q
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1900 USD
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
CY2013Q2 us-gaap Liabilities
Liabilities
1569 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-200 USD
CY2012Q4 us-gaap Liabilities
Liabilities
350 USD
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Trading Symbol
TradingSymbol
CK0001534154
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1500000 shares
dei Entity Registrant Name
EntityRegistrantName
IIM Global Corp
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
150 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
150 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2843 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2843 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12064 USD
CY2012Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
264498 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001534154
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3193 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
505929 USD
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1500000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1500000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1500000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1500000 shares
CY2013Q2 us-gaap Cash
Cash
8908 USD
CY2012Q4 us-gaap Cash
Cash
150 USD
CY2013Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
255590 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
150 USD
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
243000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 USD
CY2013Q2 us-gaap Assets
Assets
507498 USD
CY2012Q4 us-gaap Assets
Assets
150 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1569 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
350 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
507498 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
150 USD
CY2013Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
515000 USD
CY2012Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
0 USD
CY2013Q2 us-gaap Revenues
Revenues
0 USD
CY2012Q2 us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
us-gaap Revenues
Revenues
0 USD
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
8801 USD
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
750 USD
us-gaap Operating Expenses
OperatingExpenses
8871 USD
us-gaap Operating Expenses
OperatingExpenses
1500 USD
us-gaap Operating Expenses
OperatingExpenses
12064 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-8801 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-750 USD
us-gaap Net Income Loss
NetIncomeLoss
-8871 USD
us-gaap Net Income Loss
NetIncomeLoss
-1500 USD
us-gaap Net Income Loss
NetIncomeLoss
-12064 USD
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.00
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1500000 shares
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20000000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1500000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20000000 shares
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
255590 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
0 USD
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
255590 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1219 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-400 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1569 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-263242 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1900 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-266085 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
243000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
243000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-243000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-243000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2100 USD
ck0001534154 Proceeds From Issuance Of Common Stock Subscriptions
ProceedsFromIssuanceOfCommonStockSubscriptions
515000 USD
ck0001534154 Proceeds From Issuance Of Common Stock Subscriptions
ProceedsFromIssuanceOfCommonStockSubscriptions
0 USD
ck0001534154 Proceeds From Issuance Of Common Stock Subscriptions
ProceedsFromIssuanceOfCommonStockSubscriptions
515000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
517993 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8758 USD
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2011-09-21
dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
CY2012Q4 ck0001534154 Common Stock Redeemed
CommonStockRedeemed
19500000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20000000 shares
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8908 USD
CY2011Q4 us-gaap Cash
Cash
2000 USD
CY2011Q3 us-gaap Cash
Cash
0 USD
CY2012Q2 us-gaap Cash
Cash
2000 USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
1900 USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
2843 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>USE OF ESTIMATES</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</div> </div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> <b>CONCENTRATION OF RISK</b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN: justify; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif"> Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation limit as of June 30, 2013.</div> </div>
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0001
CY2012Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1950 USD
CY2013Q2 us-gaap Deferred Income Taxes And Other Assets Current
DeferredIncomeTaxesAndOtherAssetsCurrent
0 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2012Q4 ck0001534154 Percentage Of Total Outstanding Of Common Stock
PercentageOfTotalOutstandingOfCommonStock
0.67 pure
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1500000 shares
CY2013Q2 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
515000 USD
CY2013Q2 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
1910000 shares
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares

Files In Submission

Name View Source Status
0001144204-13-046065-index-headers.html Edgar Link pending
0001144204-13-046065-index.html Edgar Link pending
0001144204-13-046065.txt Edgar Link pending
0001144204-13-046065-xbrl.zip Edgar Link pending
ck0001534154-20130630.xml Edgar Link completed
ck0001534154-20130630.xsd Edgar Link pending
ck0001534154-20130630_cal.xml Edgar Link unprocessable
ck0001534154-20130630_def.xml Edgar Link unprocessable
ck0001534154-20130630_lab.xml Edgar Link unprocessable
ck0001534154-20130630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
v352493_10q.htm Edgar Link pending
v352493_ex31-1.htm Edgar Link pending
v352493_ex31-2.htm Edgar Link pending
v352493_ex32-1.htm Edgar Link pending